Four vaccines that were rare outside rich countries in 2000 now reach most of the world’s infants. What changed, where the work is left, and what came with it.
The core vaccines were widespread — 72% of infants got all three DTP doses — but the newer ones reached few children outside Europe and the Americas.
Country by country, the map rose as national programmes added the newer vaccines. The biggest gains were in the most populous countries that started from almost nothing: India, Nigeria, Pakistan.
Pneumococcal and rotavirus vaccines went from almost no infants to 71% and 61% of them in under twenty years.
37% of them live in five countries: Nigeria, DR Congo, India, Pakistan and Yemen. Where routine DTP doesn’t reach, the newer vaccines don’t either.
Missed infants = births × the share without the third dose. Births are UN estimates and projections.
Had 2000’s rate held, about 5.2 million more children would have died in 2024 alone.
Vaccines are one of several reasons, alongside malaria control, nutrition, clean water and care at birth; this data shows the change, not each cause’s share of it.
“Newer vaccines” are hepatitis B (third dose), Hib (third dose), pneumococcal conjugate (completed series) and rotavirus (completed series). A country’s reach is the mean of the four; a vaccine not yet in its schedule counts as zero. Every number in this deck is computed from these datasets by the visualization.